Clinical Trial: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Brief Summary: The purpose of this study is to evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy as primary treatment for ICNV.